Prelude Capital Management, LLC Biote Corp. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$3.14 - $6.19 $192,591 - $379,663
-61,335 Reduced 70.08%
26,191 $162,000
Q4 2022

Feb 14, 2023
SELL
$3.73 - $4.6 $14,278 - $17,608
-3,828 Reduced 4.19%
87,526 $326,000
Q3 2022

Nov 14, 2022
BUY
$3.48 - $4.98 $87,591 - $125,346
25,170 Added 38.03%
91,354 $391,000
Q2 2022

Aug 15, 2022
BUY
$3.42 - $10.06 $226,349 - $665,811
66,184 New
66,184 $250,000

Others Institutions Holding BTMD

# of Institutions
83
Shares Held
17.7M
Call Options Held
0
Put Options Held
0
View Full List

About biote Corp.

BTMD Quotes by TradingView
  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email